Related Experiment Video
Updated: Sep 10, 2025

Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
Optimizing synthetic hematocrit for cardiac MRI: a multivariable model calibrated with standardized venous sampling
Çağrı Özcan1, Hasan Yiğit2, Mehmet Serkan Çetin3
1Department of Radiology, Ankara Etimesgut Şehit Sait Ertürk State Hospital, Ulubatlı Hasan St., No: 5, Etimesgut, TR-06790, İstasyon NBHD, Ankara, Türkiye, Turkey. md.cagriozcan@gmail.com.
A new synthetic hematocrit (Hct) model uses cardiac MRI data to accurately quantify extracellular volume (ECV) without blood sampling. This method improves accuracy, especially in patients with elevated ECV, offering a non-invasive alternative for cardiac assessment.
Area of Science:
- Cardiovascular Imaging and Diagnostics
- Biomedical Engineering
- Quantitative MRI
Background:
- Cardiac magnetic resonance (CMR) is crucial for non-invasive extracellular volume (ECV) quantification.
- Venous hematocrit (Hct) measurement is typically required for ECV calculation but is susceptible to fluctuations affecting accuracy.
- Developing a reliable, non-invasive method for Hct estimation is essential for precise ECV quantification.
Purpose of the Study:
- To develop and validate a synthetic hematocrit (Hctsyn) model for accurate ECV estimation using CMR.
- To integrate patient demographics (age, sex) and blood pool T1 values into the Hctsyn model.
- To calibrate the model against an optimized venous Hct reference and evaluate its performance, particularly in hypertrophic cardiomyopathy (HCM).
Main Methods:
- Retrospective analysis of CMR data from 253 patients with diverse cardiac conditions.
- Venous Hct samples collected after a 15-minute supine rest period prior to contrast injection.
- Development of a synthetic Hct model (Hctsyn) incorporating age, sex, and pre/post-contrast blood pool T1 values.
- Calibration of the Hctsyn model using an optimized venous Hct reference.
Main Results:
- The Hctsyn model demonstrated strong agreement with measured ECV (bias: 0.31%, RMSE: 1.25, CCC: 0.949).
- In the HCM subcohort, the model showed high correlation (r=0.98) with a clinically acceptable bias (-1.16%).
- The model outperformed previous sex-specific formulas, showing improved performance (R²=0.56) and lower variability.
Conclusions:
- A standardized synthetic Hct model enables accurate, non-invasive ECV estimation without the need for blood sampling.
- This novel approach offers superior performance compared to existing methods, especially in patients with elevated ECV.
- The Hctsyn model represents a significant advancement for quantitative CMR, enhancing diagnostic precision and patient comfort.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
11:09High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System IV: CMRI